ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
혈액 배양 검사 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 14.7%로 130억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 병원 내 감염 증가, 현장진단(POC) 검사에 대한 수요 증가, 의료비 지출 증가, 규제 당국의 승인 등에 기인합니다. 예측 기간의 주요 동향으로는 원격 의료 및 원격 검사, 자동화 및 AI, 다중 검사, 패혈증 관리, 감염 감시 등이 있습니다.
감염성 질환의 발병률 증가는 혈액 배양 검사 시장의 성장을 가속할 것으로 예상됩니다. 감염성 질환은 바이러스, 세균, 곰팡이, 기생충과 같은 병원체에 의해 발생합니다. 코로나19, 결핵, 독감, 홍역, HIV, 연쇄상구균 감염과 같은 질병은 일시적인 불편함, 심각한 조직 손상 또는 사망을 유발할 수 있으며, 이러한 유해한 미생물은 외부로부터 또는 감염된 사람과의 접촉을 통해 인체에 침입합니다. 세계보건기구(WHO)는 감염병이 전 세계 사망 원인 중 2위를 차지한다고 발표했습니다. 이러한 감염 환자 증가로 인해 생명을 위협할 수 있는 균혈증이나 패혈증 감염 여부를 판단하기 위한 혈액 배양 검사에 대한 수요가 증가하고 있습니다. 예를 들어, 2024년 8월 영국 보건안전청의 보고에 따르면, 2022년 12월 31일 현재 영국에서는 주로 잉글랜드에서 3,732건의 엠팍스 환자가 확인되었으며, 2023년 5월 31일까지 잉글랜드를 중심으로 21건이 추가로 보고되었고, 스코틀랜드에서도 1건이 보고되었습니다. 보고되었습니다. 이에 따라, 감염증의 발병률 증가가 혈액 배양 검사에 대한 수요를 견인하고 있습니다.
항생제 내성균 증가는 향후 혈액배양검사 시장의 성장을 견인할 것으로 예상됩니다. 항생제 내성은 박테리아, 바이러스, 기타 미생물이 이전에 항생제나 항균제의 효과에 저항할 수 있는 능력을 의미하며, 이러한 미생물로 인한 감염을 치료하는 데 효과적이었습니다. 항생제 내성 감염이 증가함에 따라 가장 효과적인 치료법을 찾기 위해 혈액 배양 검사를 포함한 보다 종합적인 진단 검사가 필요하게 되었습니다. 예를 들어, 미국에 본부를 둔 정부 간 기구인 세계보건기구(WHO)의 2023년 11월 보고서에 따르면, 항생제 내성 감염의 경제적 영향은 2030년 1조 달러에서 2050년 1조 달러에서 3조 4,000억 달러로 증가할 것으로 예상됩니다. 이처럼 항생제 내성 증가로 인한 수요 증가가 혈액 배양 검사 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 혈액 배양 검사 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 혈액 배양 검사 시장 성장률 분석
세계의 혈액 배양 검사 시장 실적 : 규모와 성장, 2019-2024년
세계의 혈액 배양 검사 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 혈액 배양 검사 유효 시장(TAM)
제6장 시장 세분화
세계의 혈액 배양 검사 시장 : 방법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
기존/수동
자동화
세계의 혈액 배양 검사 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
소모품
기기
소프트웨어 및 서비스
세계의 혈액 배양 검사 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
배양 기술
분자 기술
마이크로어레이
PCR(중합효소 연쇄반응)
PNA-FiSH(펩티드 핵산-형광 in situ 하이브리다이제이션)
단백질체학 기술
세계의 혈액 배양 검사 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
균혈증
진균혈증
결핵균 감지
세계의 혈액 배양 검사 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 실험실
참조 실험실
학술 연구실
기타 실험실
세계의 혈액 배양 검사 시장 : 기존/수동 서브 세분화 : 방법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
혈액 배양 보틀(호기성 및 혐기성)
배지 조제
수작업에 의한 관찰과 식별
세계의 혈액 배양 검사 시장 : 자동화 서브 세분화 : 방법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
자동 혈액 배양 시스템
지속적 모니터링 시스템
통합 식별 및 감도 시험 시스템
제7장 지역별/국가별 분석
세계의 혈액 배양 검사 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 혈액 배양 검사 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
혈액 배양 검사 시장 : 경쟁 구도
혈액 배양 검사 시장 : 기업 개요
Becton, Dickinson and Company
BioMerieux SA
Thermo Fisher Scientific Inc.
Luminex Corporation
Danaher Corporation
제31장 기타 주요 기업 및 혁신 기업
Terumo Corporation
Bruker Corporation
F. Hoffmann-La Roche AG
Biobase Biotech Co. Ltd.
Scenker Biological Technology Co. Ltd.
Bulldog Bio
Anaerobe Systems Inc.
Himedia Laboratories Pvt. Ltd.
Autobio Diagnostics Co. Ltd.
Axiom Laboratories
Biosystems Inc.
BINDER GmBH
Roche Diagnostics
Mikroscan Technologies Inc.
Labotronics Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 시장의 최근 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
혈액 배양 검사 시장(2029년) - 가장 새로운 기회를 제공하는 국가
혈액 배양 검사 시장(2029년) - 가장 새로운 기회를 제공하는 부문
혈액 배양 검사 시장(2029년) - 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Blood culture tests are diagnostic procedures designed to identify disease-causing microorganisms present in the bloodstream. These tests play a crucial role in detecting infections caused by various microorganisms such as bacteria, yeast, and other foreign invaders in a blood sample.
The primary methods employed in blood culture tests include conventional/manual methods and automated methods. The conventional or manual method is utilized to detect invaders like bacteria, yeast, and other microorganisms in a blood specimen. Manual testing involves the hands-on examination and interpretation of results by skilled testers. Blood culture products encompass consumables, instruments, and software and services that leverage technologies such as culture-based technology, molecular technologies, microarrays, PCR (polymerase chain reaction), PNA-FISH (peptide nucleic acid - fluorescent in situ hybridization), and proteomics technology. These technologies are applied in the detection of bacteremia, fungemia, and mycobacterial infections. Blood culture tests are commonly utilized by hospital laboratories, reference laboratories, academic research laboratories, and other testing facilities.
The blood culture tests market research report is one of a series of new reports from The Business Research Company that provides blood culture tests market statistics, including blood culture tests industry global market size, regional shares, competitors with a blood culture tests market share, detailed blood culture tests market segments, market trends and opportunities, and any further data you may need to thrive in the blood culture tests industry. This blood culture tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood culture tests market size has grown rapidly in recent years. It will grow from $6.79 billion in 2024 to $7.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increase in prevalence of infectious diseases, aging population, advances in healthcare infrastructure, rise in research and development.
The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $13.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to rising hospital-acquired infections, growing demand for point-of-care (poc) testing, increased healthcare spending, regulatory approvals. Major trends in the forecast period include telemedicine and remote testing, automation and ai, multiplex testing, sepsis management, infectious disease surveillance.
The rising incidence of infectious diseases is expected to drive the growth of the blood culture test market. Infectious diseases are caused by pathogens such as viruses, bacteria, fungi, and parasites. These harmful microorganisms can enter the body from external sources or through contact with an infected individual. Diseases like COVID-19, tuberculosis, the flu, measles, HIV, and strep throat can cause temporary discomfort, severe tissue damage, or even death. The World Health Organization identifies infectious diseases as the second leading cause of death globally. This increase in infectious disease cases has fueled the demand for blood culture tests, which help determine whether a patient has bacteremia or septicemia, potentially life-threatening conditions. For example, in August 2024, according to a report by the UK Health Security Agency, as of December 31, 2022, there were 3,732 confirmed mpox cases in the UK, primarily in England. By May 31, 2023, 21 additional cases were reported, mainly in England, with one in Scotland. As a result, the growing incidence of infectious diseases is driving demand for blood culture tests.
The rise in antibiotic resistance is expected to drive the growth of the blood culture test market in the future. Antibiotic resistance refers to the ability of bacteria, viruses, or other microorganisms to resist the effects of antibiotics or antimicrobial drugs that were previously effective in treating infections caused by these organisms. The increase in antibiotic-resistant infections requires more comprehensive diagnostic testing, including blood culture tests, to identify the most effective treatment options. For example, in November 2023, according to a report from the World Health Organization, a US-based intergovernmental organization, antibiotic-resistant infections are projected to increase from $1 trillion in 2030 to between $1 trillion and $3.4 trillion by 2050. Thus, the rising demand due to increasing antibiotic resistance is contributing to the growth of the blood culture test market.
Technological innovation emerges as a prominent trend influencing the blood culture test market. In the dynamic landscape of pharmaceuticals, biologics, nutraceuticals, and medical devices, innovation is key to meeting evolving industry requirements. The imperative to bring new products to market efficiently and cost-effectively has led manufacturers to develop cutting-edge blood culture testing technologies. Notably, Labcorp introduced the Labcorp OnDemandTM at-home collection kit in May 2022. This innovative kit utilizes dried blood technology to measure hemoglobin A1c from a small blood sample, providing users with insights into their average blood sugar levels over time. Technological advancements like this not only enhance accuracy and safety but also enable individuals to monitor their health conveniently from the comfort of their homes, fostering the growth of the blood culture test market.
Major companies in the organic blood culture tests market are focusing on developing advanced technologies, such as clinical chemistry technologies, to improve diagnostic accuracy, decrease turnaround times, and enhance patient management through integrated testing solutions that deliver comprehensive insights into infections and related health issues. Clinical chemistry technologies refer to diagnostic methods and instruments utilized to analyze bodily fluids, primarily blood, to measure chemical components and evaluate health conditions. For example, in April 2024, Mindray Medical International Limited, a medical device company based in China, launched mid-volume laboratories. These innovations demonstrate Mindray's dedication to supporting mid-volume laboratories by offering simple yet effective solutions that boost diagnostic capabilities while meeting the growing demands of healthcare providers.
In April 2022, BioMerieux India Pvt Ltd, a provider of in vitro diagnostic solutions based in India, acquired Specific Diagnostics for an undisclosed amount. This acquisition aims to improve public health by delivering innovative in vitro diagnostic solutions. Specific Diagnostics is an India-based company that produces the SPECIFIC REVEAL Rapid AST system for testing.
Major companies operating in the blood culture tests market include Becton, Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Terumo Corporation, Bruker Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Bulldog Bio, Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Axiom Laboratories, Biosystems Inc., BINDER GmBH, Roche Diagnostics, Mikroscan Technologies Inc., Labotronics Ltd., Hardy Diagnostics, OpGen Inc., Meditech Technologies India Private Limited, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Hologic Inc., Quidel Corporation, Copan Diagnostics Inc., Greiner Bio-One International GmbH, Carl Zeiss AG, Nanosphere Health Sciences, GenMark Diagnostics, Meridian Bioscience Inc., Nikon Corporation
North America was the largest region in the blood culture tests market in 2024. The regions covered in the blood culture tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the blood culture tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The blood culture tests include revenues earned by entities by micro sampling technology and blood chemistry analyzer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Culture Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on blood culture tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for blood culture tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood culture tests market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Method: Conventional/Manual Methods; Automated Methods
2) By Product: Consumables; Instruments; Software and Services
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Blood Culture Tests Market Characteristics
3. Blood Culture Tests Market Trends And Strategies
4. Blood Culture Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Blood Culture Tests Growth Analysis And Strategic Analysis Framework
5.1. Global Blood Culture Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Blood Culture Tests Market Growth Rate Analysis
5.4. Global Blood Culture Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Blood Culture Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Blood Culture Tests Total Addressable Market (TAM)
6. Blood Culture Tests Market Segmentation
6.1. Global Blood Culture Tests Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional/Manual Methods
Automated Methods
6.2. Global Blood Culture Tests Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
Software and Services
6.3. Global Blood Culture Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture-Based Technology
Molecular Technologies
Microarrays
PCR (Polymerase Chain Reaction)
PNA-FiSH (Peptide Nucleic Acid - Fluorescent in Situ Hybridization)
Proteomics Technology
6.4. Global Blood Culture Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacteremia
Fungemia
Mycobacterial Detection
6.5. Global Blood Culture Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories
6.6. Global Blood Culture Tests Market, Sub-Segmentation Of Conventional/Manual Methods, By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Culture Bottles (Aerobic and Anaerobic)
Culture Media Preparation
Manual Observation and Identification
6.7. Global Blood Culture Tests Market, Sub-Segmentation Of Automated Methods, By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Blood Culture Systems
Continuous Monitoring Systems
Integrated Identification and Sensitivity Testing Systems
7. Blood Culture Tests Market Regional And Country Analysis
7.1. Global Blood Culture Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Blood Culture Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
